Neuromodulation specialist CVRx Launches new Barostim NEO2™ Implantable Pulse Generator
CVRx, Inc., developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure, has launched its … continue reading "Neuromodulation specialist CVRx Launches new Barostim NEO2™ Implantable Pulse Generator"
The post Neuromodulation specialist CVRx Launches new Barostim NEO2™ Implantable Pulse Generator appeared first on Medlatest - Medical Device News.